Fulcrum Therapeutics, Inc. (FULC)
NASDAQ: FULC · Real-Time Price · USD
7.02
+0.13 (1.96%)
May 8, 2026, 11:05 AM EDT - Market open
Fulcrum Therapeutics Market Cap
Fulcrum Therapeutics has a market cap or net worth of $467.43 million as of May 8, 2026. Its market cap has increased by 141.21% in one year.
Market Cap
467.43M
Enterprise Value
130.99M
1-Year Change
141.21%
Ranking
Category
Stock Price
$7.02
Market Cap Chart
Since July 18, 2019, Fulcrum Therapeutics's market cap has increased from $301.64M to $467.43M, an increase of 54.96%. That is a compound annual growth rate of 6.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 7, 2026 | 458.44M | -38.56% |
| Dec 31, 2025 | 746.12M | 194.32% |
| Dec 31, 2024 | 253.51M | -39.25% |
| Dec 29, 2023 | 417.30M | 10.13% |
| Dec 30, 2022 | 378.93M | -47.15% |
| Dec 31, 2021 | 716.95M | 124.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ocugen | 487.46M |
| Rigel Pharmaceuticals | 485.49M |
| ADC Therapeutics | 476.97M |
| Shattuck Labs | 473.14M |
| Ovid Therapeutics | 472.39M |
| Sagimet Biosciences | 471.78M |
| Lyell Immunopharma | 468.05M |
| Eupraxia Pharmaceuticals | 462.22M |